Sangamo Therapeutics Inc. (SGMO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Sangamo Therapeutics Inc.

NASDAQ: SGMO · Real-Time Price · USD
0.66
0.03 (4.23%)
At close: Sep 26, 2025, 3:59 PM
0.66
0.09%
After-hours: Sep 26, 2025, 07:57 PM EDT

Sangamo Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
41.92M 45.2M 100.44M 178.87M
Short-Term Investments
n/a 35.8M 177.19M 197.68M
Long-Term Investments
1.5M 1.5M 29.84M 88.17M
Other Long-Term Assets
13.69M 16.63M 12.25M 10.17M
Receivables
4.6M 4.07M 4.47M 6.36M
Inventory
n/a n/a n/a -88.17M
Other Current Assets
5.17M 9.26M n/a 88.17M
Total Current Assets
51.69M 94.33M 300.33M 398.77M
Property-Plant & Equipment
34.76M 52.87M 125.53M 124.7M
Goodwill & Intangibles
n/a n/a 88.28M 93.46M
Total Long-Term Assets
49.94M 70.99M 262.18M 323.15M
Total Assets
101.64M 165.32M 562.51M 721.92M
Account Payables
15.48M 15.26M 22.42M 9.76M
Deferred Revenue
7.56M n/a 51.78M 85.71M
Short-Term Debt
n/a n/a n/a 4.03M
Other Current Liabilities
14.57M 11.73M 11.88M 3.52M
Total Current Liabilities
45.8M 47.73M 111.71M 127.89M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
933K 1.19M 1.21M 1.22M
Total Long-Term Liabilities
33.06M 34.7M 155.84M 218.69M
Total Liabilities
78.86M 82.43M 267.55M 346.58M
Total Debt
30.57M 38.1M 43.11M 48.08M
Book Value
22.77M 82.89M 294.96M 375.34M
Book Value Per Share
0.11 0.48 1.91 2.60
Common Stock
2.13M 1.78M 1.67M 1.46M
Retained Earnings
-1.5B -1.41B -1.15B -956.27M
Comprehensive Income
-7.53M -4.59M -8.4M -3.99M
Shareholders Equity
22.77M 82.89M 294.96M 375.34M
Total Investments
1.5M 35.8M 207.03M 285.85M